nodes	percent_of_prediction	percent_of_DWPC	metapath
Emedastine—Lacrimation—Floxuridine—stomach cancer	0.0725	0.0772	CcSEcCtD
Emedastine—Lacrimation increased—Floxuridine—stomach cancer	0.0463	0.0493	CcSEcCtD
Emedastine—Olanzapine—HRH4—stomach cancer	0.0428	0.705	CrCbGaD
Emedastine—Stinging—Mitomycin—stomach cancer	0.0413	0.044	CcSEcCtD
Emedastine—Lacrimation—Irinotecan—stomach cancer	0.0247	0.0263	CcSEcCtD
Emedastine—Lacrimation—Fluorouracil—stomach cancer	0.0237	0.0252	CcSEcCtD
Emedastine—Stinging—Fluorouracil—stomach cancer	0.0172	0.0183	CcSEcCtD
Emedastine—Lacrimation—Docetaxel—stomach cancer	0.0171	0.0182	CcSEcCtD
Emedastine—Eye irritation—Fluorouracil—stomach cancer	0.0163	0.0174	CcSEcCtD
Emedastine—Lacrimation increased—Irinotecan—stomach cancer	0.0158	0.0168	CcSEcCtD
Emedastine—Discomfort—Floxuridine—stomach cancer	0.0157	0.0167	CcSEcCtD
Emedastine—Lacrimation increased—Fluorouracil—stomach cancer	0.0151	0.0161	CcSEcCtD
Emedastine—Keratitis—Capecitabine—stomach cancer	0.015	0.016	CcSEcCtD
Emedastine—Nervous system disorder—Floxuridine—stomach cancer	0.0149	0.0159	CcSEcCtD
Emedastine—Vision blurred—Mitomycin—stomach cancer	0.0138	0.0147	CcSEcCtD
Emedastine—Olanzapine—HTR1A—stomach cancer	0.0124	0.204	CrCbGaD
Emedastine—Discomfort—Mitomycin—stomach cancer	0.0123	0.0131	CcSEcCtD
Emedastine—Eye irritation—Docetaxel—stomach cancer	0.0118	0.0125	CcSEcCtD
Emedastine—Lacrimation—Epirubicin—stomach cancer	0.0115	0.0123	CcSEcCtD
Emedastine—Eye irritation—Capecitabine—stomach cancer	0.0114	0.0121	CcSEcCtD
Emedastine—Asthenia—Floxuridine—stomach cancer	0.0109	0.0116	CcSEcCtD
Emedastine—Lacrimation increased—Docetaxel—stomach cancer	0.0109	0.0116	CcSEcCtD
Emedastine—Lacrimation—Doxorubicin—stomach cancer	0.0107	0.0114	CcSEcCtD
Emedastine—Lacrimation increased—Capecitabine—stomach cancer	0.0106	0.0112	CcSEcCtD
Emedastine—Keratitis—Epirubicin—stomach cancer	0.0104	0.0111	CcSEcCtD
Emedastine—Pain—Mitomycin—stomach cancer	0.0102	0.0109	CcSEcCtD
Emedastine—Keratitis—Doxorubicin—stomach cancer	0.00967	0.0103	CcSEcCtD
Emedastine—Rash—Floxuridine—stomach cancer	0.0096	0.0102	CcSEcCtD
Emedastine—Dermatitis—Floxuridine—stomach cancer	0.00959	0.0102	CcSEcCtD
Emedastine—Headache—Floxuridine—stomach cancer	0.00953	0.0101	CcSEcCtD
Emedastine—Dry eye—Capecitabine—stomach cancer	0.00899	0.00957	CcSEcCtD
Emedastine—Asthenia—Mitomycin—stomach cancer	0.00857	0.00912	CcSEcCtD
Emedastine—Stinging—Epirubicin—stomach cancer	0.00837	0.00891	CcSEcCtD
Emedastine—Eye pain—Capecitabine—stomach cancer	0.00782	0.00833	CcSEcCtD
Emedastine—Stinging—Doxorubicin—stomach cancer	0.00774	0.00824	CcSEcCtD
Emedastine—Rash—Mitomycin—stomach cancer	0.00753	0.00802	CcSEcCtD
Emedastine—Dermatitis—Mitomycin—stomach cancer	0.00752	0.00801	CcSEcCtD
Emedastine—Headache—Mitomycin—stomach cancer	0.00748	0.00796	CcSEcCtD
Emedastine—Lacrimation increased—Epirubicin—stomach cancer	0.00735	0.00783	CcSEcCtD
Emedastine—Rhinitis—Irinotecan—stomach cancer	0.00732	0.00779	CcSEcCtD
Emedastine—Sinusitis—Fluorouracil—stomach cancer	0.00731	0.00778	CcSEcCtD
Emedastine—Rhinitis—Fluorouracil—stomach cancer	0.00701	0.00746	CcSEcCtD
Emedastine—Lacrimation increased—Doxorubicin—stomach cancer	0.00681	0.00724	CcSEcCtD
Emedastine—Cardiac disorder—Irinotecan—stomach cancer	0.00677	0.00721	CcSEcCtD
Emedastine—Abnormal dreams—Epirubicin—stomach cancer	0.0067	0.00713	CcSEcCtD
Emedastine—Dry eye—Epirubicin—stomach cancer	0.00626	0.00666	CcSEcCtD
Emedastine—Abnormal dreams—Doxorubicin—stomach cancer	0.0062	0.0066	CcSEcCtD
Emedastine—Dry eye—Doxorubicin—stomach cancer	0.00579	0.00617	CcSEcCtD
Emedastine—Vision blurred—Fluorouracil—stomach cancer	0.00574	0.00611	CcSEcCtD
Emedastine—Olanzapine—ALB—stomach cancer	0.00555	0.0914	CrCbGaD
Emedastine—Eye pain—Epirubicin—stomach cancer	0.00545	0.0058	CcSEcCtD
Emedastine—Discomfort—Irinotecan—stomach cancer	0.00535	0.00569	CcSEcCtD
Emedastine—Discomfort—Fluorouracil—stomach cancer	0.00512	0.00545	CcSEcCtD
Emedastine—Nervous system disorder—Irinotecan—stomach cancer	0.00509	0.00541	CcSEcCtD
Emedastine—Rhinitis—Docetaxel—stomach cancer	0.00506	0.00539	CcSEcCtD
Emedastine—Eye pain—Doxorubicin—stomach cancer	0.00504	0.00537	CcSEcCtD
Emedastine—Rhinitis—Capecitabine—stomach cancer	0.0049	0.00521	CcSEcCtD
Emedastine—Nervous system disorder—Fluorouracil—stomach cancer	0.00487	0.00519	CcSEcCtD
Emedastine—Tachycardia—Fluorouracil—stomach cancer	0.00485	0.00516	CcSEcCtD
Emedastine—Eye disorder—Docetaxel—stomach cancer	0.00472	0.00502	CcSEcCtD
Emedastine—Cardiac disorder—Docetaxel—stomach cancer	0.00468	0.00499	CcSEcCtD
Emedastine—Eye disorder—Capecitabine—stomach cancer	0.00457	0.00486	CcSEcCtD
Emedastine—Cardiac disorder—Capecitabine—stomach cancer	0.00453	0.00483	CcSEcCtD
Emedastine—Pain—Irinotecan—stomach cancer	0.00443	0.00472	CcSEcCtD
Emedastine—Mental disorder—Docetaxel—stomach cancer	0.00442	0.00471	CcSEcCtD
Emedastine—Dysgeusia—Docetaxel—stomach cancer	0.0043	0.00458	CcSEcCtD
Emedastine—Mental disorder—Capecitabine—stomach cancer	0.00428	0.00456	CcSEcCtD
Emedastine—Pain—Fluorouracil—stomach cancer	0.00425	0.00452	CcSEcCtD
Emedastine—Dysgeusia—Capecitabine—stomach cancer	0.00416	0.00443	CcSEcCtD
Emedastine—Vision blurred—Capecitabine—stomach cancer	0.00401	0.00427	CcSEcCtD
Emedastine—Asthenia—Irinotecan—stomach cancer	0.00372	0.00396	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.00371	0.00395	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.0036	0.00383	CcSEcCtD
Emedastine—Discomfort—Capecitabine—stomach cancer	0.00358	0.00381	CcSEcCtD
Emedastine—Sinusitis—Epirubicin—stomach cancer	0.00356	0.00379	CcSEcCtD
Emedastine—Nervous system disorder—Docetaxel—stomach cancer	0.00352	0.00374	CcSEcCtD
Emedastine—Pruritus—Fluorouracil—stomach cancer	0.00351	0.00374	CcSEcCtD
Emedastine—Tachycardia—Docetaxel—stomach cancer	0.0035	0.00373	CcSEcCtD
Emedastine—Skin disorder—Docetaxel—stomach cancer	0.00348	0.00371	CcSEcCtD
Emedastine—Rhinitis—Epirubicin—stomach cancer	0.00341	0.00363	CcSEcCtD
Emedastine—Nervous system disorder—Capecitabine—stomach cancer	0.0034	0.00362	CcSEcCtD
Emedastine—Eye disorder—Methotrexate—stomach cancer	0.0034	0.00362	CcSEcCtD
Emedastine—Tachycardia—Capecitabine—stomach cancer	0.00339	0.00361	CcSEcCtD
Emedastine—Cardiac disorder—Methotrexate—stomach cancer	0.00338	0.00359	CcSEcCtD
Emedastine—Skin disorder—Capecitabine—stomach cancer	0.00337	0.00359	CcSEcCtD
Emedastine—Sinusitis—Doxorubicin—stomach cancer	0.00329	0.0035	CcSEcCtD
Emedastine—Rash—Irinotecan—stomach cancer	0.00327	0.00348	CcSEcCtD
Emedastine—Dermatitis—Irinotecan—stomach cancer	0.00327	0.00348	CcSEcCtD
Emedastine—Headache—Irinotecan—stomach cancer	0.00325	0.00346	CcSEcCtD
Emedastine—Mental disorder—Methotrexate—stomach cancer	0.00319	0.00339	CcSEcCtD
Emedastine—Eye disorder—Epirubicin—stomach cancer	0.00318	0.00339	CcSEcCtD
Emedastine—Cardiac disorder—Epirubicin—stomach cancer	0.00316	0.00336	CcSEcCtD
Emedastine—Rhinitis—Doxorubicin—stomach cancer	0.00316	0.00336	CcSEcCtD
Emedastine—Rash—Fluorouracil—stomach cancer	0.00313	0.00333	CcSEcCtD
Emedastine—Dermatitis—Fluorouracil—stomach cancer	0.00313	0.00333	CcSEcCtD
Emedastine—Headache—Fluorouracil—stomach cancer	0.00311	0.00331	CcSEcCtD
Emedastine—Dysgeusia—Methotrexate—stomach cancer	0.0031	0.0033	CcSEcCtD
Emedastine—Pain—Docetaxel—stomach cancer	0.00307	0.00326	CcSEcCtD
Emedastine—Vision blurred—Methotrexate—stomach cancer	0.00298	0.00318	CcSEcCtD
Emedastine—Mental disorder—Epirubicin—stomach cancer	0.00298	0.00317	CcSEcCtD
Emedastine—Pain—Capecitabine—stomach cancer	0.00297	0.00316	CcSEcCtD
Emedastine—Eye disorder—Doxorubicin—stomach cancer	0.00294	0.00313	CcSEcCtD
Emedastine—Cardiac disorder—Doxorubicin—stomach cancer	0.00292	0.00311	CcSEcCtD
Emedastine—Dysgeusia—Epirubicin—stomach cancer	0.0029	0.00309	CcSEcCtD
Emedastine—Vision blurred—Epirubicin—stomach cancer	0.00279	0.00297	CcSEcCtD
Emedastine—Mental disorder—Doxorubicin—stomach cancer	0.00276	0.00294	CcSEcCtD
Emedastine—Dysgeusia—Doxorubicin—stomach cancer	0.00268	0.00286	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00268	0.00285	CcSEcCtD
Emedastine—Discomfort—Methotrexate—stomach cancer	0.00266	0.00284	CcSEcCtD
Emedastine—Vision blurred—Doxorubicin—stomach cancer	0.00258	0.00275	CcSEcCtD
Emedastine—Asthenia—Docetaxel—stomach cancer	0.00257	0.00274	CcSEcCtD
Emedastine—Pruritus—Docetaxel—stomach cancer	0.00254	0.0027	CcSEcCtD
Emedastine—Nervous system disorder—Methotrexate—stomach cancer	0.00253	0.0027	CcSEcCtD
Emedastine—Skin disorder—Methotrexate—stomach cancer	0.00251	0.00267	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00251	0.00267	CcSEcCtD
Emedastine—Discomfort—Epirubicin—stomach cancer	0.00249	0.00265	CcSEcCtD
Emedastine—Asthenia—Capecitabine—stomach cancer	0.00249	0.00265	CcSEcCtD
Emedastine—Pruritus—Capecitabine—stomach cancer	0.00246	0.00261	CcSEcCtD
Emedastine—Nervous system disorder—Epirubicin—stomach cancer	0.00237	0.00252	CcSEcCtD
Emedastine—Tachycardia—Epirubicin—stomach cancer	0.00236	0.00251	CcSEcCtD
Emedastine—Skin disorder—Epirubicin—stomach cancer	0.00235	0.0025	CcSEcCtD
Emedastine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00232	0.00247	CcSEcCtD
Emedastine—Discomfort—Doxorubicin—stomach cancer	0.00231	0.00246	CcSEcCtD
Emedastine—Rash—Docetaxel—stomach cancer	0.00226	0.00241	CcSEcCtD
Emedastine—Dermatitis—Docetaxel—stomach cancer	0.00226	0.0024	CcSEcCtD
Emedastine—Headache—Docetaxel—stomach cancer	0.00225	0.00239	CcSEcCtD
Emedastine—Pain—Methotrexate—stomach cancer	0.00221	0.00235	CcSEcCtD
Emedastine—Nervous system disorder—Doxorubicin—stomach cancer	0.00219	0.00234	CcSEcCtD
Emedastine—Rash—Capecitabine—stomach cancer	0.00219	0.00233	CcSEcCtD
Emedastine—Dermatitis—Capecitabine—stomach cancer	0.00219	0.00233	CcSEcCtD
Emedastine—Tachycardia—Doxorubicin—stomach cancer	0.00218	0.00232	CcSEcCtD
Emedastine—Headache—Capecitabine—stomach cancer	0.00217	0.00232	CcSEcCtD
Emedastine—Skin disorder—Doxorubicin—stomach cancer	0.00217	0.00231	CcSEcCtD
Emedastine—Pain—Epirubicin—stomach cancer	0.00207	0.0022	CcSEcCtD
Emedastine—Pain—Doxorubicin—stomach cancer	0.00191	0.00204	CcSEcCtD
Emedastine—Asthenia—Methotrexate—stomach cancer	0.00185	0.00197	CcSEcCtD
Emedastine—Pruritus—Methotrexate—stomach cancer	0.00183	0.00195	CcSEcCtD
Emedastine—Asthenia—Epirubicin—stomach cancer	0.00173	0.00185	CcSEcCtD
Emedastine—Pruritus—Epirubicin—stomach cancer	0.00171	0.00182	CcSEcCtD
Emedastine—Rash—Methotrexate—stomach cancer	0.00163	0.00173	CcSEcCtD
Emedastine—Dermatitis—Methotrexate—stomach cancer	0.00163	0.00173	CcSEcCtD
Emedastine—Headache—Methotrexate—stomach cancer	0.00162	0.00172	CcSEcCtD
Emedastine—Asthenia—Doxorubicin—stomach cancer	0.00161	0.00171	CcSEcCtD
Emedastine—Pruritus—Doxorubicin—stomach cancer	0.00158	0.00169	CcSEcCtD
Emedastine—Rash—Epirubicin—stomach cancer	0.00152	0.00162	CcSEcCtD
Emedastine—Dermatitis—Epirubicin—stomach cancer	0.00152	0.00162	CcSEcCtD
Emedastine—Headache—Epirubicin—stomach cancer	0.00151	0.00161	CcSEcCtD
Emedastine—Rash—Doxorubicin—stomach cancer	0.00141	0.0015	CcSEcCtD
Emedastine—Dermatitis—Doxorubicin—stomach cancer	0.00141	0.0015	CcSEcCtD
Emedastine—Headache—Doxorubicin—stomach cancer	0.0014	0.00149	CcSEcCtD
